(Q44834065)

6 December 2017

1 reference

title

The controversies surrounding the management of uterine serous carcinoma (English)

1 reference

6 December 2017

Adnan R Munkarah

1

1 reference

PubMed ID

15389471

6 December 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

6 December 2017

3

1 reference

inferred from page(s)

published in

Cancer

1 reference

6 December 2017

101

1 reference

6 December 2017

10

1 reference

6 December 2017

2152-2154

1 reference

p53 expression in neoplasms of the uterine corpus.

6 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

Optimal management for surgically Stage 1 serous cancer of the uterus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

Endometrial cancer: predictors of peritoneal failure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

Predictors of lymphatic failure in endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

Treatment of uterine papillary serous carcinoma with paclitaxel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20651

7 January 2021

Identifiers

DOI

10.1002/CNCR.20651

1 reference

6 December 2017

1 reference

PubMed ID

15389471